JD Health International Inc.
JDHIF
$6.27
$1.1722.95%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 8.09B | 7.84B | 7.58B | 7.56B | 7.57B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 8.09B | 7.84B | 7.58B | 7.56B | 7.57B |
| Cost of Revenue | 6.24B | 6.06B | 5.87B | 5.87B | 5.89B |
| Gross Profit | 1.85B | 1.78B | 1.71B | 1.69B | 1.68B |
| SG&A Expenses | 1.50B | 1.47B | 1.43B | 1.42B | 1.41B |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 7.92B | 7.71B | 7.48B | 7.46B | 7.48B |
| Operating Income | 161.37M | 135.28M | 109.20M | 100.47M | 92.64M |
| Income Before Tax | 666.81M | 562.66M | 457.53M | 419.77M | 383.71M |
| Income Tax Expenses | 88.87M | 92.03M | 95.05M | 86.30M | 77.78M |
| Earnings from Continuing Operations | 577.94 | 470.63 | 362.48 | 333.47 | 305.93 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 671.20K | 502.40K | 332.90K | 94.10K | -147.50K |
| Net Income | 578.61M | 471.13M | 362.81M | 333.56M | 305.78M |
| EBIT | 161.37M | 135.28M | 109.20M | 100.47M | 92.64M |
| EBITDA | 182.48M | 156.88M | 131.28M | 123.13M | 116.00M |
| EPS Basic | 0.18 | 0.15 | 0.12 | 0.11 | 0.10 |
| Normalized Basic EPS | 0.13 | 0.11 | 0.09 | 0.08 | 0.08 |
| EPS Diluted | 0.18 | 0.15 | 0.12 | 0.11 | 0.10 |
| Normalized Diluted EPS | 0.13 | 0.11 | 0.09 | 0.08 | 0.08 |
| Average Basic Shares Outstanding | 12.57B | 12.55B | 12.53B | 12.51B | 12.49B |
| Average Diluted Shares Outstanding | 12.64B | 12.64B | 12.64B | 12.65B | 12.66B |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |